Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
about
Nanoparticles for brain drug deliveryA blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to BrainRecent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingBypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia TherapyPeptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approachesEnabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicinesPathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriersInteraction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanismsDevelopmental and pathological angiogenesis in the central nervous systemBlood-CNS Barrier Impairment in ALS patients versus an animal modelNanoscale drug delivery systems and the blood-brain barrierNew therapeutic approaches for Krabbe disease: The potential of pharmacological chaperonesGetting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrierNanomedicine in Central Nervous System (CNS) Disorders: A Present and Future ProspectiveOral Delivery of Protein Drugs Bioencapsulated in Plant CellsGlioblastoma Stem-Like Cells: Characteristics, Microenvironment, and TherapyNanoparticles for imaging and treating brain cancerNew clathrin-based nanoplatforms for magnetic resonance imagingWnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitroA new brain drug delivery strategy: focused ultrasound-enhanced intranasal drug deliveryBrain delivery of proteins via their fatty acid and block copolymer modificationsOf drug administration, war and oïkos: mediating cancer with nanomedicines.The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure.Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive propertiesAlzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of StrokeLead optimization studies of cinnamic amide EP2 antagonistsTargeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?Identification of peptide sequences that target to the brain using in vivo phage display.Nanotechnology in drug delivery and tissue engineering: from discovery to applicationsLysolipid containing liposomes for transendothelial drug deliveryPolymersomes as an effective drug delivery system for glioma--a review.Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses.Enhanced Transport Capabilities via Nanotechnologies: Impacting Bioefficacy, Controlled Release Strategies, and Novel Chaperones.Novel central nervous system drug delivery systems.Plasmonics-enhanced and optically modulated delivery of gold nanostars into brain tumor.
P2860
Q21285117-26C53702-8C83-4B7F-BCC8-D20D1013EB3DQ24612655-C9C92B6E-C0FD-487D-B521-BC7237E90256Q26745586-515F19FA-EFCC-4B0E-92FD-D54E66087C6CQ26778234-8F955897-DEE4-4244-AF80-9444063F9193Q26780502-F3BB574C-83CF-4BEC-B3BB-C7648CE2D08EQ26795570-0500BD0D-5D8D-46BB-800D-2697A46CC24EQ26850868-F5D02868-3643-4CB8-8BEA-BE261E64DF69Q26852773-C006DE5F-0146-4AC0-A18B-84DF0BD3B529Q27001177-1D04E0A3-F9C3-433C-94B5-DFC303B3CFF2Q27023250-84D16BEA-13BE-431C-B955-2FFA8E0D08A5Q27026792-86532EA6-3549-4A55-871E-54A734A43EDFQ27026978-76222217-99F8-4F02-AC7B-A14475780E19Q28068142-1E54ACEE-47AC-4483-A936-95AB95B4FB16Q28071873-3F1664B3-BF6D-41B2-843D-E79710FDC224Q28075999-CEA8193C-489A-480D-A117-7660C8697274Q28079063-8D720A50-5E9B-44DE-9491-8090A44FB0B4Q28079663-E094BB98-69EF-495A-A208-191D8B687469Q28394053-9DB6C7B7-8CA5-4DA5-B12A-A3B3E016B79CQ28483110-F5E66CCF-7672-42AF-9BC7-64635C01A393Q28535094-683A04E7-A7F4-47C0-BE20-8D592275AF4BQ28543529-F040B1F6-A235-483F-99AE-442C54E595B7Q30354932-F3380C12-8C1E-4B29-837C-FD16D7CFF589Q30380301-053DB322-2E0B-46EE-8A5F-40037C552371Q30407897-518190FC-BB60-4DD4-BFC2-379CE9C5DB04Q30572687-BBF4616E-4663-4EBF-ABEF-5E2B1EBCC4E6Q30666219-F6011356-540F-46DE-8E8C-7DC83079E5B6Q31065446-17A803C0-CE58-4330-A2A2-62EEC094CED7Q33565967-A29D0993-20F2-4F2A-A6C6-29DCB080AB66Q33654575-D7E1F4F4-54F9-4518-B528-00A69D43FC79Q33864330-1FCF9CA6-FA05-4FF5-B0FA-C6E755D3AA54Q33893813-B4FDD47A-071E-4645-994F-B4BE0A2E9962Q33972613-4663A78B-AB0C-4005-8F75-4D75AA145A50Q34112647-C3632890-4E4B-449A-8E85-140545833068Q34227171-03724DDA-AC8E-45ED-8178-24678582BF8CQ34420100-C551176B-85EE-4A0C-B725-62B593869E5CQ34532194-5705F7F6-BFC0-4437-92D5-B5377282B1B8Q34539778-D8F16127-77D3-4B03-971C-4F0B0A8AFA87Q34983770-8E868086-E535-49F9-ACC6-038E04227F96Q35064473-0F368988-D3C1-4A49-AC44-3FD956EE1E06Q35118176-C0CBF69E-9DBF-4294-A9A7-32261AF83966
P2860
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Approaches to transport therap ...... rrier to treat brain diseases.
@en
Approaches to transport therap ...... rrier to treat brain diseases.
@nl
type
label
Approaches to transport therap ...... rrier to treat brain diseases.
@en
Approaches to transport therap ...... rrier to treat brain diseases.
@nl
prefLabel
Approaches to transport therap ...... rrier to treat brain diseases.
@en
Approaches to transport therap ...... rrier to treat brain diseases.
@nl
P1476
Approaches to transport therap ...... rrier to treat brain diseases.
@en
P2093
Reinhard Gabathuler
P356
10.1016/J.NBD.2009.07.028
P577
2009-08-05T00:00:00Z